Dr. Barzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 Duarte Rd
Duarte, CA 91010- Is this information wrong?
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2008 - 2011
- University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2001 - 2004
- Tehran University of Medical Sciences School of MedicineClass of 1996
Certifications & Licensure
- CA State Medical License 2011 - 2025
- NV State Medical License 2023 - 2025
- AK State Medical License 2022 - 2024
- RI State Medical License 2021 - 2024
- OH State Medical License 2008 - 2011
- TX State Medical License 2005 - 2008
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
Clinical Trials
- Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer Start of enrollment: 2013 Aug 02
- Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Start of enrollment: 2015 Mar 01
- 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab Start of enrollment: 2018 Feb 27
- Join now to see all
Publications & Presentations
PubMed
- Racial and ethnic disparities in self-reported general and mental health status among colorectal cancer survivors: impact of sociodemographic factors and implications ...Paul S Yoon, Stephanie Navarro, Afsaneh Barzi, Carol Y Ochoa-Dominguez, Angel Arizpe, Albert J Farias> ;Quality of Life Research. 2024 Mar 1
- Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-line Treatment of KRAS-mutant Metastatic Colorectal Cancer: A Phase 1b Clinical Study.Ahn, D., Ridinger, M., Samuëlsz, E., Subramanian, R., Croucher, P., Smeal, T., Barzi, A., Kabbinavar, F., Lenz, H.> ;Clinical Cancer Research. 2024 Jan 17
- (HER2) amplifications and co-occurringalterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.Weipert, C., Espenschied, C., Raymond, V., Gordon, E., Barzi, A., Wang-Gillam, A., Nezami, M., Mahadevan, D., Mody, K.> ;Frontiers in Oncology. 2024 Jan 1
- Join now to see all
Lectures
- Patient-reported outcomes (PRO) before and after colorectal cancer (CRC) by race in a national survey.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Total cost of care for patients (pts) with stage II colon cancer (CC-II): A SEER-Medicare analysis.2019 ASCO Annual Meeting - 6/1/2019
- Potential Role of Polymorphisms in the Transporter Genes ENT1 and MATE1/OCT2 in Predicting TAS-102 Efficacy and Toxicity in Patients with Refractory Metastatic Colorec...2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
- Cardiff Oncology to Present New Data from Lead Clinical Program in KRAS-Mutated Metastatic Colorectal Cancer on September 8, 2021August 25th, 2021
- Trovagene : Announces Acceptance of Phase 1b/2 KRAS-Mutated Metastatic Colorectal Cancer Trial Abstract for Presentation at the 2020 ASCO Annual MeetingJune 16th, 2020
- Onvansertib Show Early Signals of Safety and Efficacy in KRAS-Mutated mCRCOctober 23rd, 2019
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- Keck Hospital of USCLos Angeles, California
- USC Norris Comprehensive Cancer CenterLos Angeles, California
- City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: